Research output per year
Research output per year
Fingerprint
Dive into the research topics where Mingjiang Xu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
HoxBlinc lncRNA reprograms CTCF-independent TADs to drive leukemic transcription and HSC dysregulation in NUP98-rearranged leukemia
Hamamoto, K., Zhu, G., Lai, Q., Lesperance, J., Luo, H., Li, Y., Nigam, N., Sharma, A., Yang, F. C., Claxton, D., Qiu, Y., Aplan, P. D., Xu, M. & Huang, S., Apr 1 2025, In: Journal of Clinical Investigation. 135, 7, e184743.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
PSPC1 exerts an oncogenic role in AML by regulating a leukemic transcription program in cooperation with PU.1
Hong, J., Sui, P., Li, Y., Xu, K. Y., Lee, J. H., Wang, J., Chen, S., Zhang, P., Wingate, N., Noor, A., Yuan, Y., Hromas, R., Zhou, H., Hamamoto, K., Su, R., Yin, C. C., Ye, F., Quesada, A. E., Chen, J. & Huang, S. & 5 others, , Mar 6 2025, In: Cell Stem Cell. 32, 3, p. 463-478.e6Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
DDX18 coordinates nucleolus phase separation and nuclear organization to control the pluripotency of human embryonic stem cells
Shi, X., Li, Y., Zhou, H., Hou, X., Yang, J., Malik, V., Faiola, F., Ding, J., Bao, X., Modic, M., Zhang, W., Chen, L., Mahmood, S. R., Apostolou, E., Yang, F. C., Xu, M., Xie, W., Huang, X., Chen, Y. & Wang, J., Dec 2024, In: Nature communications. 15, 1, 10803.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
MiR-223-3p promotes genomic stability of hematopoietic progenitors after radiation
Chen, S., Srinivasan, G., Jaiswal, A., Williamson, E. A., Li, L., Arris, D., Zhou, D., Xu, M. & Hromas, R., Jan 2024, In: Experimental Hematology. 129, 104123.Research output: Contribution to journal › Article › peer-review
Open Access -
RNA m5C oxidation by TET2 regulates chromatin state and leukaemogenesis
Zou, Z., Dou, X., Li, Y., Zhang, Z., Wang, J., Gao, B., Xiao, Y., Wang, Y., Zhao, L., Sun, C., Liu, Q., Yu, X., Wang, H., Hong, J., Dai, Q., Yang, F. C., Xu, M. & He, C., Oct 24 2024, In: Nature. 634, 8035, p. 986-994 9 p.Research output: Contribution to journal › Article › peer-review
Open Access17 Scopus citations
Datasets
-
Additional file 2 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726547.v1, https://springernature.figshare.com/articles/dataset/Additional_file_2_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726547/1
Dataset
-
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5075029.v1, https://springernature.figshare.com/collections/Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/5075029/1
Dataset
-
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5075029, https://springernature.figshare.com/collections/Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/5075029
Dataset
-
Additional file 3 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726550, https://springernature.figshare.com/articles/dataset/Additional_file_3_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726550
Dataset
-
Additional file 3 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726550.v1, https://springernature.figshare.com/articles/dataset/Additional_file_3_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726550/1
Dataset